Charles P Lewis1, Deniz Doruk Camsari1, A Irem Sonmez1, Aiswarya Lakshmi Nandakumar1, Marjorie A Gresbrink1, Zafiris J Daskalakis2, Paul E Croarkin3. 1. Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. 2. Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Temerty Centre for Therapeutic Brain Intervention, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada. 3. Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. Electronic address: croarkin.paul@mayo.edu.
Abstract
BACKGROUND: Suicide is a leading cause of death among youth. Prior research using transcranial magnetic stimulation (TMS) has implicated deficits in GABAergic cortical inhibition in adolescent suicidal behavior, yet no studies have assessed whether cortical inhibition varies over time in conjunction with changes in suicidal ideation (SI). This study examined dynamic changes in long-interval intracortical inhibition (LICI), a TMS measure of GABAB-mediated inhibition, and their relationship with changes in SI in a small sample of adolescents undergoing pharmacologic treatment for depression. METHODS: Ten depressed adolescents (aged 13-17) underwent clinical assessment and TMS testing at baseline and again at follow-up. All were treated with antidepressant medication in the interim. SI was measured with the Columbia Suicide Severity Rating Scale (C-SSRS) Intensity of Ideation subscale. LICI was measured at interstimulus intervals of 100 and 150 ms. RESULTS: There was a significant partial correlation, controlling for change in depression severity, between ΔLICI-100 and change in SI as measured by ΔC-SSRS (ρ = .746, df = 7, p = .021), which remained after also controlling for time to follow-up assessment (ρ = .752, df = 6, p = .032). No significant correlation was observed between ΔLICI-150 and change in SI. LIMITATIONS: Sample size; variable follow-up interval; inability to control for age, sex, and potential treatment effects. CONCLUSIONS: These data offer preliminary signal of an association between increases in GABAB-mediated cortical inhibition and reduction in SI over time in adolescents treated for depression. Further studies are warranted to explore the role of cortical inhibition in adolescent suicidal ideation and behavior.
BACKGROUND: Suicide is a leading cause of death among youth. Prior research using transcranial magnetic stimulation (TMS) has implicated deficits in GABAergic cortical inhibition in adolescent suicidal behavior, yet no studies have assessed whether cortical inhibition varies over time in conjunction with changes in suicidal ideation (SI). This study examined dynamic changes in long-interval intracortical inhibition (LICI), a TMS measure of GABAB-mediated inhibition, and their relationship with changes in SI in a small sample of adolescents undergoing pharmacologic treatment for depression. METHODS: Ten depressed adolescents (aged 13-17) underwent clinical assessment and TMS testing at baseline and again at follow-up. All were treated with antidepressant medication in the interim. SI was measured with the Columbia Suicide Severity Rating Scale (C-SSRS) Intensity of Ideation subscale. LICI was measured at interstimulus intervals of 100 and 150 ms. RESULTS: There was a significant partial correlation, controlling for change in depression severity, between ΔLICI-100 and change in SI as measured by ΔC-SSRS (ρ = .746, df = 7, p = .021), which remained after also controlling for time to follow-up assessment (ρ = .752, df = 6, p = .032). No significant correlation was observed between ΔLICI-150 and change in SI. LIMITATIONS: Sample size; variable follow-up interval; inability to control for age, sex, and potential treatment effects. CONCLUSIONS: These data offer preliminary signal of an association between increases in GABAB-mediated cortical inhibition and reduction in SI over time in adolescents treated for depression. Further studies are warranted to explore the role of cortical inhibition in adolescent suicidal ideation and behavior.
Authors: A Sequeira; T Klempan; L Canetti; J ffrench-Mullen; C Benkelfat; G A Rouleau; G Turecki Journal: Mol Psychiatry Date: 2007-03-13 Impact factor: 15.992
Authors: Mark J Smith; Linda F Adams; Peter J Schmidt; David R Rubinow; Eric M Wassermann Journal: Biol Psychiatry Date: 2003-10-01 Impact factor: 13.382
Authors: T A Klempan; A Sequeira; L Canetti; A Lalovic; C Ernst; J ffrench-Mullen; G Turecki Journal: Mol Psychiatry Date: 2007-10-16 Impact factor: 15.992
Authors: Charles P Lewis; Paul A Nakonezny; Caren J Blacker; Jennifer L Vande Voort; John D Port; Gregory A Worrell; Hang Joon Jo; Zafiris J Daskalakis; Paul E Croarkin Journal: Neuropsychopharmacology Date: 2018-03-14 Impact factor: 7.853
Authors: B P Chang; J C Franklin; J D Ribeiro; K R Fox; K H Bentley; E M Kleiman; M K Nock Journal: Transl Psychiatry Date: 2016-09-13 Impact factor: 6.222
Authors: Parmis Fatih; M Utku Kucuker; Jennifer L Vande Voort; Deniz Doruk Camsari; Faranak Farzan; Paul E Croarkin Journal: Front Psychiatry Date: 2021-06-02 Impact factor: 4.157
Authors: Mehmet Utku Kucuker; Ammar G Almorsy; Ayse Irem Sonmez; Anna N Ligezka; Deniz Doruk Camsari; Charles P Lewis; Paul E Croarkin Journal: Front Hum Neurosci Date: 2021-06-25 Impact factor: 3.169